Sign In
Buy PTCT
$68.68
+0.450 (+0.660%)
At Close: Jun 03, 2026
PTC Therapeutics, Inc. (PTCT) Q3 2025 Earnings Call Transcript
04:20am, Wednesday, 05'th Nov 2025
PTC Therapeutics, Inc. ( PTCT ) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST Company Participants Ellen Cavaleri Matthew Klein - CEO & Director Eric Pauwels - Chief Business Officer Pierre Gravi
Compared to Estimates, PTC Therapeutics (PTCT) Q3 Earnings: A Look at Key Metrics
07:01pm, Tuesday, 04'th Nov 2025
The headline numbers for PTC Therapeutics (PTCT) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall St
PTC Therapeutics (PTCT) Q3 Earnings and Revenues Top Estimates
06:26pm, Tuesday, 04'th Nov 2025
PTC Therapeutics (PTCT) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of a loss of $1.19 per share. This compares to a loss of $1.39 per share a year ago.
PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
04:01pm, Tuesday, 04'th Nov 2025
– Initiated US and EU launch of Sephience™ (sepiapterin) – – Strong initial Sephience uptake with global revenue of $19.6M and 521 start forms in the US as of September 30 – – Robust Q3
PTC Therapeutics, Inc. $PTCT Shares Acquired by Y Intercept Hong Kong Ltd
03:41am, Monday, 03'rd Nov 2025
Y Intercept Hong Kong Ltd grew its position in PTC Therapeutics, Inc. (NASDAQ: PTCT) by 458.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Comm
PTC Therapeutics to Participate at Upcoming Investor Conferences
08:00am, Friday, 31'st Oct 2025
WARREN, N.J. , Oct. 31, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences: UBS Global Healthcare Conference 2025 Tu
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
11:08am, Tuesday, 28'th Oct 2025
PTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Monday, 27'th Oct 2025
WARREN, N.J. , Oct. 27, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Oct. 23, 2025, the company approved non-statutory stock options to purchase an aggregate of 2
Allspring Global Investments Holdings LLC Purchases 2,258 Shares of PTC Therapeutics, Inc. $PTCT
03:47am, Friday, 24'th Oct 2025
Allspring Global Investments Holdings LLC increased its position in shares of PTC Therapeutics, Inc. (NASDAQ: PTCT) by 22.0% during the undefined quarter, according to its most recent filing with the
PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2025 Financial Results
08:00am, Tuesday, 21'st Oct 2025
WARREN, N.J. , Oct. 21, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its third quarter 2025 financial resu
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Wednesday, 01'st Oct 2025
WARREN, N.J. , Oct. 1, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Sept.
PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment
01:56pm, Monday, 08'th Sep 2025
On Saturday, BioMarin Pharmaceutical Inc. BMRN released new Phase 3 PEGASUS study results on Saturday.
PTC Therapeutics, Inc. (PTCT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
12:44pm, Monday, 08'th Sep 2025
PTC Therapeutics, Inc. (NASDAQ:PTCT ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 9:15 AM EDT Company Participants Matthew Klein - CEO & Director Pierre Gravier - Chief F
PTC Therapeutics, Inc. (PTCT) Presents At Cantor Global Healthcare Conference 2025 Transcript
10:20pm, Sunday, 07'th Sep 2025
PTC Therapeutics, Inc. (NASDAQ:PTCT ) Cantor Global Healthcare Conference 2025 September 3, 2025 8:35 AM EDT Company Participants Matthew Klein - CEO & Director Pierre Gravier - Chief Financial Office
PTC Therapeutics, Inc. (PTCT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
09:25pm, Sunday, 07'th Sep 2025
PTC Therapeutics, Inc. (NASDAQ:PTCT ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 11:00 AM EDT Company Participants Matthew Klein - CEO & Director Pierre Gravier - Chief Finan
